SynBioBeta Speaker

Maria Lence

For Women's Health

CEO & Founder

Maria Lence is the Founder and CEO of For Women’s Health, a platform dedicated to advancing women’s health by addressing the needs of both healthcare providers and the women they serve.Maria’s journey began with her personal experience navigating a complex and fragmented healthcare system. It took 5 years and consultations with 15 health providers to receive a correct diagnosis and treatment for a common hormonal imbalance—an experience that underscored a systemic issue, not a clinical one. This realization became the catalyst for applying her professional background in technology to drive meaningful change in women’s health.As an early employee in globally successful marketplaces like Booking.com, Expedia, TripAdvisor, Maria developed a deep expertise in leveraging technology to solve complex problems. She has a strong track record of growing businesses through consultative, data-driven strategies—building new revenue streams, launching business units, developing go-to-market strategies, and forging key partnerships.oblly

Sessions Featuring

Maria

This Year

Femtech

•

12:00 PM

-

12:45 PM

Human Health

Engineering Reproduction

From AI-powered drug discovery to genomic selection and ovarian longevity — one of the most technically complex and ethically charged frontiers in biotech.The biology of reproduction has always carried the weight of the human story. Now it carries the weight of the possible.Ovarian aging is being mapped at the molecular level. Genomic selection is moving from research settings into clinical practice. AI is accelerating drug discovery for conditions that have been chronically underfunded and chronically misunderstood. The tools exist. The data is accumulating. The ethical frameworks are being written in real time — by the scientists in this room.

Featuring

Aristea Grammoustianou

Impli AG

Biosensor Tech Dev Lead

Lauren Avenius

Node Labs

CEO

Deena Emera

Buck Institute

Senior Scientist

Maria Lence

For Women's Health

CEO & Founder

Carmen Messerlian

Vie Science

CEO & Founder

Femtech

•

12:00 PM

-

12:45 PM

Human Health

Engineering Reproduction

From AI-powered drug discovery to genomic selection and ovarian longevity — one of the most technically complex and ethically charged frontiers in biotech.The biology of reproduction has always carried the weight of the human story. Now it carries the weight of the possible.Ovarian aging is being mapped at the molecular level. Genomic selection is moving from research settings into clinical practice. AI is accelerating drug discovery for conditions that have been chronically underfunded and chronically misunderstood. The tools exist. The data is accumulating. The ethical frameworks are being written in real time — by the scientists in this room.

Featuring

Aristea Grammoustianou

Impli AG

Biosensor Tech Dev Lead

Lauren Avenius

Node Labs

CEO

Deena Emera

Buck Institute

Senior Scientist

Maria Lence

For Women's Health

CEO & Founder

Carmen Messerlian

Vie Science

CEO & Founder

Femtech

•

12:00 PM

-

12:45 PM

Human Health

Engineering Reproduction

From AI-powered drug discovery to genomic selection and ovarian longevity — one of the most technically complex and ethically charged frontiers in biotech.The biology of reproduction has always carried the weight of the human story. Now it carries the weight of the possible.Ovarian aging is being mapped at the molecular level. Genomic selection is moving from research settings into clinical practice. AI is accelerating drug discovery for conditions that have been chronically underfunded and chronically misunderstood. The tools exist. The data is accumulating. The ethical frameworks are being written in real time — by the scientists in this room.

Featuring

Lauren Avenius

Node Labs

CEO

Aristea Grammoustianou

Impli AG

Biosensor Tech Dev Lead

Maria Lence

For Women's Health

CEO & Founder

Deena Emera

Buck Institute

Senior Scientist

Carmen Messerlian

Vie Science

CEO & Founder

Femtech

•

12:00 PM

-

12:45 PM

Human Health

Engineering Reproduction

From AI-powered drug discovery to genomic selection and ovarian longevity — one of the most technically complex and ethically charged frontiers in biotech.The biology of reproduction has always carried the weight of the human story. Now it carries the weight of the possible.Ovarian aging is being mapped at the molecular level. Genomic selection is moving from research settings into clinical practice. AI is accelerating drug discovery for conditions that have been chronically underfunded and chronically misunderstood. The tools exist. The data is accumulating. The ethical frameworks are being written in real time — by the scientists in this room.

Featuring

Lauren Avenius

Node Labs

CEO

Aristea Grammoustianou

Impli AG

Biosensor Tech Dev Lead

Maria Lence

For Women's Health

CEO & Founder

Deena Emera

Buck Institute

Senior Scientist

Carmen Messerlian

Vie Science

CEO & Founder

Previous Speakers Include